NOV 30, 2018
Cornea/External Disease, Dry Eye
In this interview from AAO 2018, Dr. Penny Asbell provides an update on a multicenter DREAM study evaluating omega-3 treatment for dry eye. In this clinical trial, patients with dry eye were given either omega-3 (2000-mg eicosapentaenoic acid and 1000-mg docosahexaenoic acid daily) or refined olive oil (5000 mg) and followed for 1 year. Both cohorts showed similar levels of improvement at the end of the study. Based on these findings, which were published in the The New England Journal of Medicine, Dr. Asbell recommends physicians consider other approved and already available therapies for treating patients with dry eye.
Relevant Financial Disclosures: Dr. Asbell receives grant support from NEI and the Office of Dietary Supplements, NIH